Control of HIV replication in astrocytes by a family of highly conserved host proteins with a common Rev-interacting domain (Risp)

AIDS

Volumn 24, Issue 16, 2010, Pages 2433-2442

  Vincendeau, Michelle ^a   Kramer, Susanne ^a,g   Hadian, Kamyar ^a,c   Rothenaigner, Ina ^a   Bell, Jeanne ^d   Hauck, Stefanie M ^b   Bickel, Christian ^a   Nagel, Daniel ^a,c   Kremmer, Elisabeth ^c   Werner, Thomas ^e   Leib Mösch, Christine ^a,f   Brack Werner, Ruth ^a  

^a Institute of Molecular Virology   (Germany)

^b Department of Protein Science ^*  (Germany)

^c INSTITUTE OF EPIDEMIOLOGY   (Germany)

^d UNIVERSITY OF EDINBURGH   (United Kingdom)

^e Genomatix GmbH   (Germany)

^f UNIVERSITY OF HEIDELBERG   (Germany)

^g MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Astrocyte; Brain; FAM21; HIV; Latency; Reservoir; Rev

Indexed keywords

ANTIGEN P24; COMPLEMENTARY DNA; GAG PROTEIN; REV PROTEIN; RISP PROTEIN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; VIRUS RNA;

AFFINITY CHROMATOGRAPHY; ARTICLE; ASTROCYTE; BRAIN TISSUE; CELL ISOLATION; CELL LYSATE; CELL NUCLEUS; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE SILENCING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN TISSUE; PLASMID; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN INTERACTION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRUS REPLICATION; WESTERN BLOTTING;

ASTROCYTES; BLOTTING, WESTERN; CELLS, CULTURED; DNA-BINDING PROTEINS; HIV INFECTIONS; HIV-1; HUMANS; REV GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; VIRUS REPLICATION;

EID: 78549250000     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0b013e32833e8758     Document Type: Article

References (47)

1. Nickle DC, Shriner D, Mittler JE, Frenkel LM, Mullins JI. Importance and detection of virus reservoirs and compartments of HIV infection. Curr Opin Microbiol 2003;6:410-416.
2. Pierson T, McArthur J, Siliciano RF. Reservoirs for HIV-1: mechanisms for viral persistence in the presence of antiviral immune responses and antiretroviral therapy. Annu Rev Immunol 2000;18:665-708.
3. Alexaki A, Liu Y, Wigdahl B. Cellular reservoirs of HIV-1 and their role in viral persistence. Curr HIV Res 2008;6:388-400.
4. Shen L, Siliciano RF. Viral reservoirs, residual viremia, and the potential of highly active antiretroviral therapy to eradicate HIV infection. J Allergy Clin Immunol 2008;122:22-28.
5. Richman DD, Margolis DM, Delaney M, Greene WC, Hazuda D, Pomerantz RJ. The challenge of finding a cure for HIV infection. Science 2009;323:1304-1307.
6. Jeeninga RE, Westerhout EM, van Gerven ML, Berkhout B. HIV- 1 latency in actively dividing human T cell lines. Retrovirology 2008;5:37.
7. Lawrence DM, Major EO. HIV-1 and the brain: connections between HIV-1-associated dementia, neuropathology and neu- roimmunology. Microbes Infect 2002;4:301-308.
8. Kramer-Hammerle S, Rothenaigner I, Wolff H, Bell JE, Brack- Werner R. Cells of the central nervous system as targets and reservoirs of the human immunodeficiency virus. Virus Res 2005;111:194-213.
9. Gorry PR, Ong C, Thorpe J, Bannwarth S, Thompson KA, Gatignol A, et al. Astrocyte infection by HIV-1: mechanisms of restricted virus replication, and role in the pathogenesis of HIV-1-associated dementia. Curr HIV Res 2003;1:463-473.
10. Brack-Werner R. Astrocytes: HIV cellular reservoirs and important participants in neuropathogenesis. AIDS 1999;13:1-22.
11. Neumann M, Felber BK, Kleinschmidt A, Froese B, Erfle V, Pavlakis GN, Brack-Werner R. Restriction of human immunodeficiency virus type 1 production in a human astrocytoma cell line is associated with a cellular block in Rev function. J Virol 1995;69:2159-2167.
12. Ludwig E, Silberstein FC, van Empel J, Erfle V, Neumann M, Brack-Werner R. Diminished rev-mediated stimulation of human immunodeficiency virus type 1 protein synthesis is a hallmark of human astrocytes. J Virol 1999;73:8279-8289.
13. Neumann M, Afonina E, Ceccherini-Silberstein F, Schlicht S, Erfle V, Pavlakis GN, Brack-Werner R. Nucleocytoplasmic transport in human astrocytes: decreased nuclear uptake of the HIV Rev shuttle protein. J Cell Sci 2001;114:1717-1729.
14. Brack-Werner R, Kleinschmidt A, Ludvigsen A, Mellert W, Neumann M, Herrmann R, et al. Infection of human brain cells by HIV-1: restricted virus production in chronically infected human glial cell lines. AIDS 1992; 6:273-285.
15. Felber BK, Zolotukhin AS, Pavlakis GN. Posttranscriptional control of HIV-1 and other retroviruses and its practical applications. Adv Pharmacol 2007; 55:161-197.
16. Kjems J, Askjaer P. Rev protein and its cellular partners. Adv Pharmacol 2000;48:251-298.
17. Groom HC, Anderson EC, Dangerfield JA, Lever AM. Rev regulates translation of human immunodeficiency virus type 1 RNAs. J Gen Virol 2009;90:1141-1147.
18. Lever AM. HIV-1 RNA packaging. Adv Pharmacol 2007;55:1-32.
19. Kramer-Hämmerle S, Ceccherini-Silberstein F, Bickel C, Wolff H, Vincendeau M, Werner T, et al. Identification of a novel Rev-interacting cellular protein. BMC Cell Biol 2005; 6:20.
20. Wolff H, Brack-Werner R, Neumann M, Werner T, Schneider R. Integrated functional and bioinformatics approach for the identification and experimental verification of RNA signals: application to HIV-1 INS. Nucleic Acids Res 2003;31:2839-2851.
21. Wolff H, Hadian K, Ziegler M, Weierich C, Kramer-Hammerle S, Kleinschmidt A, et al. Analysis of the influence of subcellular localization of the HIV Rev protein on Rev-dependent gene expression by multifluorescence live-cell imaging. Exp Cell Res 2006;312:443-456.
22. Hadian K, Vincendeau M, Maeusbacher N, Nagel D, Hauck SM, Ueffing M, et al. Identification of an hnRNP-recognition region in the HIV Rev protein. J Biol Chem 2009;284:33384-33391.
23. Villa A, Snyder EY, Vescovi A, Martinez-Serrano A. Establishment and properties of a growth factor-dependent, perpetual neural stem cell line from the human CNS. Exp Neurol 2000;161 :67-84.
24. Rothenaigner I, Kramer S, Ziegler M, Wolff H, Kleinschmidt A, Brack-Werner R. Long-term HIV-1 infection of neural progenitor populations. AIDS 2007;21:2271-2281.
25. Radonic A, Thulke S, Mackay iM, Landt O, Siegert W, Nitsche A. Guideline to reference gene selection for quantitative realtime PCR. Biochem Biophys Res Commun 2004;313:856-862.
26. Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 2001;29:e45.
27. Modem S, Reddy TR. An antiapoptotic protein, Hax-1, inhibits the HIV-1 rev function by altering its sub-cellular localization. J Cell Physiol 2008;214:14-19.
28. Fang J, Kubota S, Yang B, Zhou N, Zhang H, Godbout R, Pomerantz RJ. A DEAD box protein facilitates HIV-1 replication as a cellular co-factor of Rev. Virology 2004;330:471-480.
29. FangJ, Acheampong E, Dave R, Wang F, Mukhtar M, Pomerantz RJ. The RNA helicase DDX1 is involved in restricted HIV-1 Rev function in human astrocytes. Virology 2005;336:299-307.
30. Modem S, Badri KR, Holland TC, Reddy TR. Sam68 is absolutely required for Rev function and HIV-1 production. Nucleic Acids Res 2005; 33:873-879.
31. Suhasini M, Reddy TR. Cellular proteins and HIV-1 Rev function. Curr HIV Res 2009;7:91-100.
32. Li J, Liu Y, Kim BO, HeJJ. Direct participation of Sam68, the 68- kilodalton Src-associated protein in mitosis, in the CRM1- mediated Rev nuclear export pathway. J Virol 2002; 76: 8374-8382.
33. Li J, Liu Y, Park iW, He JJ. Expression of exogenous Sam68, the 68-kilodalton SRC-associated protein in mitosis, is able to alleviate impaired Rev function in astrocytes. J Virol 2002;76:4526-4535.
34. Bachoo RM, Kim RS, Ligon KL, Maher EA, Brennan C, Billings N, et al. Molecular diversity of astrocytes with implications for neurological disorders. Proc Natl Acad Sci U S A 2004; 101 :8384-8389.
35. Ong CL, Thorpe JC, Gorry PR, Bannwarth S, Jaworowski A, Howard JL, et al. Low TRBP levels support an innate human immunodeficiency virus type 1 resistance in astrocytes by enhancing the PKR antiviral response. J Virol 2005; 79: 12763-12772.
36. Wortman B, Darbinian N, Sawaya BE, Khalili K, Amini S. Evidence for regulation of long terminal repeat transcription by Wnt transcription factor TCF-4 in human astrocytic cells. J Virol 2002;76:11159-11165.
37. Carroll-Anzinger D, Kumar A, Adarichev V, Kashanchi F, Al- Harthi L. Human immunodeficiency virus-restricted replication in astrocytes and the ability of gamma interferon to modulate this restriction are regulated by a downstream effector of the Wnt signaling pathway. J Virol 2007; 81:5864-5871.
38. Saito Y, Sharer LR, Epstein LG, MichaelsJ, Mintz M, Louder M, et al. Overexpression of nef as a marker for restricted HIV-1 infection of astrocytes in postmortem pediatric central nervous tissues. Neurology 1994; 44:474-481.
39. Nuovo GJ, Gallery F, MacConnell P, Braun A. In situ detection of polymerase chain reaction-amplified HIV-1 nucleic acids and tumor necrosis factor-alpha RNA in the central nervous system. Am J Pathol 1994;144:659-666.
40. Tornatore C, Chandra R, Berger JR, Major EO. HIV-1 infection of subcortical astrocytes in the pediatric central nervous system. Neurology 1994; 44:481-487.
41. Ranki A, Nyberg M, Ovod V, Haltia M, Elovaara i, Raininko R, et al. Abundant expression of HIV Nef and Rev proteins in brain astrocytes in vivo is associated with dementia. AIDS 1995; 9:1001-1008.
42. Takahashi K, Wesselingh SL, Griffin DE, McArthurJC, Johnson RT, Glass JD. Localization of HIV-1 in human brain using polymerase chain reaction/in situ hybridization and immuno- cytochemistry. Ann Neurol 1996;39:705-711.
43. Trillo-Pazos G, Diamanturos A, Rislove L, Menza T, Chao W, Belem P, et al. Detection of HIV-1 DNA in microglia/macro- phages, astrocytes and neurons isolated from brain tissue with HIV-1 encephalitis by laser capture microdissection. Brain Pathol 2003;13:144-154.
44. Anderson CE, Tomlinson GS, Pauly B, Brannan FW, Chiswick A, Brack-Werner R, et al. Relationship of Nef-positive and GFAP- reactive astrocytes to drug use in early and late HIV infection. Neuropathol Appl Neurobiol 2003; 29:378-388.
45. Churchill MJ, Wesselingh SL, Cowley D, Pardo CA, McArthur JC, Brew BJ, Gorry PR. Extensive astrocyte infection is prominent in human immunodeficiency virus-associated dementia. Ann Neurol 2009; 66:253-258.
46. Kaul M. HIV's double strike at the brain: neuronal toxicity and compromised neurogenesis. Front Biosci 2008; 13:2484-2494.
47. Bobbitt KR, Addo MM, Altfeld M, Filzen T, Onafuwa AA, Walker BD, Collins KL. Rev activity determines sensitivity of HIV-1- infected primary T cells to CTL killing. Immunity 2003; 18:289-299.